In 2024, SIA "Lotos Pharma" had revenue of 4.5 million EUR and profit of 766.7 thousand EUR. The company has 33 employees. Beneficial owners: Kaspars Ivanovs.
year | Revenue | Profit | Assets | Liabilities | Equity | Employees |
|---|---|---|---|---|---|---|
| 2024 | 4 486 102 € +7.2% | 766 708 € +7.8% | 4 097 945 € +25.9% | 1 326 560 € | 2 771 385 € | 34 +9.7% |
| 2023 | 4 185 403 € +19.9% | 711 351 € -5.4% | 3 255 640 € +50.0% | 1 188 830 € | 2 066 810 € | 31 +10.7% |
| 2022 | 3 489 413 € +49.2% | 751 715 € +246.5% | 2 169 908 € +57.0% | 814 449 € | 1 355 459 € | 28 +27.3% |
| 2021 | 2 339 011 € +33.0% | 216 971 € +12.1% | 1 381 778 € +25.6% | 778 034 € | 603 744 € | 22 +29.4% |
Overall Rating | A+97/100 |
Financial Health | 100/100 |
Credit History | 100/100 |
Legal History | 100/100 |
Business Activity | 80/100 |
| Overall Risk | Low |
No risk flags | |
No tax debts | |
Positive profit | |
Regular report filing | |
| Name, Surname | Position | Representation Rights | Registered | |
|---|---|---|---|---|
| Board Member | Independently |
| Name | Changed |
|---|---|
| SIA "Lotos pharma" | 19 August 2020 |
SIA "Lotos Pharma" is located at Mārupes nov., Mārupe, Plieņciema iela 16.
In 2024, SIA "Lotos Pharma" had revenue of 4 486 102 EUR and profit of 766 708 EUR. Compared to previous year, revenue increased by 7.2%. View full financial report →
In 2024, SIA "Lotos Pharma" had an average of 33 employees. View tax history →
The beneficial owners of SIA "Lotos Pharma" are Kaspars Ivanovs. View ownership details →
Yes, SIA "Lotos Pharma" is registered as an active VAT payer with VAT number LV40103638962.
In 2024, the average gross salary at SIA "Lotos Pharma" was approximately 1484,63 € per month (net ~ 1119,97 €). This is an approximate calculation. View salary details →
SIA "Lotos Pharma" was founded on February 19, 2013. The company has been operating for 13 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company Age | 13 years | 12 - 16 | 41% | |
Net Revenue | 4 486 102,00 € | 2 - 6 | 84% | |
Profit | 766 708,00 € | 1 - 5 | 91% | |
Equity | 2 771 385,00 € | 1 - 5 | 88% | |
Assets | 4 097 945,00 € | 1 - 5 | 91% | |
Fixed Assets | 1 499 533,00 € | - | 90% | |
Investments | 435,00 € | - | 10% | |
Liquidity | 4.67 | - | 90% | |
Profitability | 17.1% | - | 40% | |
Registered Capital | 2828,00 € | - | 10% |
| Name, Surname | Shares | Ownership Rights | 2024 dividends | |
|---|---|---|---|---|
| Kaspars Ivanovs | 101 | 100.00% | 613 366,00 € |
| Name, Surname | Nationality | Birth Date |
|---|
| Name | Registration Number | Relationship |
|---|---|---|
| SIA "Farmācijas, biomedicīnas un medicīnas tehnoloģiju Kompetences centrs" | 40103991773 | Subsidiary (14.5%) |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Annual financial report for 2019.
Annual financial report for 2018.
Annual financial report for 2017.
Annual financial report for 2016.
Annual financial report for 2015.
New name: SIA "Lotos pharma"
New registered capital: 2828 EUR.
Registered in the Latvian Company Register.
Registered as a VAT payer.
| Kaspars Ivanovs | LV |